Long non-coding RNA expressed in aggressive cancer
Patent
·
OSTI ID:1568646
The invention described in the application relates to a long non-coding RNA expressed in cancer. The invention thus provides methods and compositions for evaluating levels of the long non-coding RNA to assess the aggressiveness of a cancer and for modulating levels of the long non-coding RNA.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-05CH11231
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 10,364,470
- Application Number:
- 15/353,710
- OSTI ID:
- 1568646
- Country of Publication:
- United States
- Language:
- English
Similar Records
Centromere/kinetochore protein genes for cancer diagnosis, prognosis and treatment selection
Structural architecture of the human long non-coding RNA, steroid receptor RNA activator
Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway
Patent
·
2022
·
OSTI ID:1925056
Structural architecture of the human long non-coding RNA, steroid receptor RNA activator
Journal Article
·
2012
· Nucleic Acids Research
·
OSTI ID:1625497
Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway
Journal Article
·
2015
· Biochemical and Biophysical Research Communications
·
OSTI ID:22592794